An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.
about
Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Geissoschizine methyl ether protects oxidative stress-mediated cytotoxicity in neurons through the 'Neuronal Warburg Effect'Yokukansan enhances the proliferation of B65 neuroblastomaTherapies for Parkinson's diseases: alternatives to current pharmacological interventions.The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease: A study protocol of a randomized, double blind, placebo-controlled pilot trial.
P2860
Q30249553-DD830D57-27EE-49A2-B227-35BBDFBFBA87Q36925905-9DA04C4E-2A6E-456B-B516-61B514D57A9CQ36951967-7077FDDD-D97D-4871-A207-E3842EE17576Q37544068-8F44579B-CBA6-4DA4-B03E-5296DA063C3CQ38925121-E38D884A-B524-4D12-B17F-D7A5E56BA035Q53053726-BFDD9D01-CFC5-400F-ABB6-F1C300A79603Q55692910-315F427A-01CD-48A3-A552-8AC64BF4CBD4
P2860
An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
An exploratory study of the ef ...... ents with Parkinson's disease.
@en
An exploratory study of the ef ...... ents with Parkinson's disease.
@nl
type
label
An exploratory study of the ef ...... ents with Parkinson's disease.
@en
An exploratory study of the ef ...... ents with Parkinson's disease.
@nl
prefLabel
An exploratory study of the ef ...... ents with Parkinson's disease.
@en
An exploratory study of the ef ...... ents with Parkinson's disease.
@nl
P2093
P2860
P50
P1476
An exploratory study of the ef ...... ents with Parkinson's disease.
@en
P2093
Tadaaki Kawanabe
Toshiki Fujioka
Yasuo Iwasaki
Yasuo Terayama
Yokukansan Parkinson’s Disease Study Group
P2860
P2888
P304
P356
10.1007/S00702-013-1105-Y
P577
2013-10-30T00:00:00Z